Posted in | News | Petrochemicals

BASF and Pacific NorthWest LNG Agree on Use of BASF’s OASE® Gas Treatment Technology

BASF and Pacific NorthWest LNG have concluded a license agreement on the use of BASF’s OASE® technology for the removal of carbon dioxide and sulfur containing components from natural gas for all trains of Pacific NorthWest LNG’s proposed liquefied natural gas (LNG) facility in the district of Port Edward, near Prince Rupert, British Columbia, Canada.

The facility anticipates shipping first gas to customers by the end of 2018. The use of BASF’s OASE technology for Gas Treating is essential for the production of liquefied natural gas (LNG).

BASF’s OASE technology removes contaminants contained in the gas to enable its liquefaction at temperatures of about minus 160 degrees Celsius. The technology has a proven track record in LNG facilities around the globe and its robustness and flexibility to meet stringent removal requirements is well recognized in the industry. Dr. Andreas Northemann, Head of the Global Gas Treatment business in BASF’s Intermediates division, said: “We are pleased to work together with Pacific NorthWest LNG to provide the optimum solution for their facility. This cooperation is another milestone in enhancing and building on our long term presence in Canada.” BASF has been present in Canada since 1954 with headquarters in Mississauga, Ontario and has manufacturing and sales sites across Canada.

Front-End Engineering and Design (FEED) for the LNG facility is currently ongoing with three international engineering contractors. The FEED is expected to be complete and in time for a Final Investment Decision by the end of 2014.

With more than 40 years of experience, BASF offers its customers efficient solutions for the treatment of various gases such as natural gas, synthesis gas, and biogas. Worldwide, these solutions have been proven and demonstrated in over 350 reference plants. BASF markets its range of technologies, gas treatment agents and complete technical services under the brand OASE – Gas Treating Excellence by BASF.

About Pacific NorthWest LNG

Pacific NorthWest LNG is a proposed liquefied natural gas (LNG) export facility on Lelu Island within the District of Port Edward, British Columbia, on land administered by the Prince Rupert Port Authority. The facility, representing an investment of $9 billion to $11 billion, would export natural gas produced by Progress Energy Canada in northeast B.C. Both Pacific NorthWest LNG and Progress Canada Energy are majority-owned by PETRONAS, Malaysia’s national energy company. JAPEX is a minority shareholder in Pacific NorthWest LNG and its associated natural gas supply. For more information about Pacific NorthWest LNG, please visit www.pacificnorthwestlng.com.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    BASF Corporation. (2019, February 08). BASF and Pacific NorthWest LNG Agree on Use of BASF’s OASE® Gas Treatment Technology. AZoM. Retrieved on November 21, 2024 from https://www.azom.com/news.aspx?newsID=39314.

  • MLA

    BASF Corporation. "BASF and Pacific NorthWest LNG Agree on Use of BASF’s OASE® Gas Treatment Technology". AZoM. 21 November 2024. <https://www.azom.com/news.aspx?newsID=39314>.

  • Chicago

    BASF Corporation. "BASF and Pacific NorthWest LNG Agree on Use of BASF’s OASE® Gas Treatment Technology". AZoM. https://www.azom.com/news.aspx?newsID=39314. (accessed November 21, 2024).

  • Harvard

    BASF Corporation. 2019. BASF and Pacific NorthWest LNG Agree on Use of BASF’s OASE® Gas Treatment Technology. AZoM, viewed 21 November 2024, https://www.azom.com/news.aspx?newsID=39314.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.